Leading the worldwide fight to treat and cure
Tay-Sachs, Canavan, GM1 and Sandhoff diseases

  • 1

Latest News

  • 1
  • 2

 

NTSAD leads the worldwide fight to treat and cure
Tay-Sachs, Canavan, GM1, and Sandhoff diseases
by driving research, forging collaboration, and fostering community.

Supporting families is the center of everything we do.

Join us, learn more, and support our cause.

 

A “pseudodeficiency allele” reduces enzyme activity but does not cause a disease. A pseudodeficiency allele does not cause Tay-Sachs disease in a carrier or in the children who inherit the pseudodeficiency allele. Even if a person has one Tay-Sachs mutation and one pseudodeficiency allele, they will not develop Tay-Sachs disease. Approximately 30% of non-Ashkenazi Jewish and 3% of Ashkenazi Jewish individuals who are identified as carriers by enzyme analysis have a benign pseudodeficiency allele.

Login